Application of stereotactic body radiotherapy in extracranial metastases

doi:10.3760/cma.j.issn.1673-422X.2014.11.007

Abstract

LIN Gang, WANG Zhun, XU Ya-Ping. Application of stereotactic body radiotherapy in extracranial metastases[J]. Journal of International Oncology, 2014, 41(11): 820-823.

［1］ Hiraki M, Nishimura J, Ohtsuka M, et al. Impact of stereotactic body radiotherapy on colorectal cancer with distant metastases［J］. Oncol Rep, 2014, 31(2):795799. ［2］ Mehta N, Selch M, Wang PC, et al. Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma［J］. Sarcoma, 2013, 2013:360214. ［3］ Baschnagel AM, Mangona VS, Robertson JM, et al. Lung metastases treated with imageguided stereotactic body radiation therapy［J］. Clin Oncol (R Coll Radiol), 2013, 25(4):236241. ［4］ Habermehl D, Herfarth KK, Bermejo JL, et al. Singledose radiosurgical treatment for hepatic metastasestherapeutic outcome of 138 treated lesions from a single institution［J］. Radiat Oncol, 2013, 8:175. ［5］ Garg AK, Shiu AS, Yang J, et al. Phase 1/2 trial of singlesession stereotactic body radiotherapy for previously unirradiated spinal metastases［J］. Cancer, 2012, 118(20):50695077. ［6］ Bae SH, Kim MS, Cho CK, et al. High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases［J］. J Surg Oncol, 2012, 106(2):138143. ［7］ Park HJ, Kim HJ, Won JH, et al. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?［J］. Technol Cancer Res Treat, 2014， In Press. ［8］ Kirkpatrick JP, Brenner DJ, Orton CG. The linearquadratic model is inappropriate to model high dose per fraction effects in radiosurgery［J］. Medical Phys, 2009, 36(8):33813384. ［9］ Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?［J］. Int J Radiat Oncol Biol Phys Int J Radiat Oncol Biol Phys, 88(2):254262. ［10］ Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response［J］. Cancer Cell, 2005, 8(2):8991. ［11］ Lee Y, Auh SL, Wang Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment［J］. Blood, 2009, 114(3):589595. ［12］ Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multiinstitutional phase Ⅰ/Ⅱ trial of stereotactic body radiation therapy for liver metastases［J］. J Clin Oncol, 2009, 27(10):15721578. ［13］ Rule W, Timmerman R, Tong L, et al. Phase Ⅰ doseescalation study of stereotactic body radiotherapy in patients with hepatic metastases［J］. An Surg Oncol, 2011, 18(4):10811087. ［14］ Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer［J］. JAMA, 2010, 303(11):10701076. ［15］ Dhakal S, Corbin KS, Milano MT, et al. Stereotactic body radiotherapy for pulmonary metastases from softtissue sarcomas: excellent local lesion control and improved patient survival［J］. Int J Radiat Oncol Biol Phys, 2012, 82(2):940945. ［16］ Inoue T, Oh RJ, Shiomi H, et al. Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory events［J］. Strahlenther Onkol, 2013, 189(4):285292. ［17］ Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for lung metastases［J］. Lung Cancer, 2012, 75(1):7781. ［18］ Han K, Cheung P, Basran PS, et al. A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors［J］. Radiother Oncol, 2010, 95(1):103108. ［19］ Ahmed KA, Stauder MC, Miller RC, et al. Stereotactic body radiation therapy in spinal metastases［J］. Int J Radiat Oncol Biol Phys, 2012, 82(5):e803809. ［20］ Sahgal A, Ames C, Chou D, et al. Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases［J］. Int J Radiat Oncol Biol Phys, 2009, 74(3):723731. ［21］ Massicotte E, Foote M, Reddy R, et al. Minimal access spine surgery (MASS) for decompression and stabilization performed as an outpatient procedure for metastatic spinal tumours followed by spine stereotactic body radiotherapy (SBRT): first report of technique and preliminary outcomes［J］. Technol Cancer Res Treat, 2012, 11(1):1525. ［22］ Boehling NS, Grosshans DR, Allen PK,et al. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases［J］. J Neurosurg Spine, 2012, 16(4):379386. ［23］ Alongi F, Arcangeli S, Filippi AR, et al. Review and uses of stereotactic body radiation therapy for oligometastases［J］. Oncologist, 2012, 17(8):11001107. ［24］ Salama JK, Hasselle MD, Chmura SJ, et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease［J］. Cancer, 2012, 118(11):29622970. ［25］ Ranck MC, Golden DW, Corbin KS, et al. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma［J］. Am J Clin Oncol, 2013, 36(6):589595. ［26］ Blanco AI, Teh BS, Amato RJ. Role of radiation therapy in the management of renal cell cancer［J］. Cancers, 2011, 3(4):40104023. ［27］ Hui Z, Tretiakova M, Zhang Z, et al. Radiosensitization by inhibiting STAT1 in renal cell carcinoma［J］. Int J Radiat Oncol Biol Phys Int J Radiat Oncol Biol Phys, 2009, 73(1):288295. ［28］ Kijima T, Koga F, Fujii Y,et al. Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1［J］. PLoS One, 2013, 8(5):e64615. ［29］ Wersll PJ, Blomgren H, Lax I, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma［J］. Radiother Oncol， 2005， 77(1):8895. ［30］ Anbalagan S, Pires IM, Blick C, et al. Radiosensitization of renal cell carcinoma in vitro through the induction of autophagy［J］. Radiother Oncol, 2012, 103(3):388393. ［31］ Seung SK, Curti BD, Crittenden M, et al. Phase 1 study of stereotactic body radiotherapy and interleukin2tumor and immunological responses［J］. Sci Transl Med, 2012, 4(137):137ra74. ［32］ Kao J, Chen CT, Tong CC, et al. Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases : Final report of a prospective clinical trial［J］. Target Oncol, 2014, 9(2): 145153. ［33］ De Ruysscher D, Wanders R, van Baardwijk A, et al. Radical treatment of nonsmallcell lung cancer patients with synchronous oligometastases: longterm results of a prospective phase Ⅱ trial (Nct01282450) ［J］. J Thorac Oncol, 2012, 7(10):15471555.

[1]	Li Ping, Sun Xiaonan. Application of the combination of stereotactic body radiation therapy and immune checkpoint inhibitors in non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(2): 116-120.
[2]	Zhang Lili, Yu Yonghua. Research progress of stereotactic body radiation therapy for lung oligometastases of colorectal cancer [J]. Journal of International Oncology, 2020, 47(10): 630-633.
[3]	Cai Liang, Shen Yali. Application of stereotactic body radiation therapy in advanced renal cell carcinoma [J]. Journal of International Oncology, 2019, 46(10): 627-630.
[4]	Su Chuanghuang, Li Derui. Several problems about the stereotactic body radiation therapy for lung cancer [J]. Journal of International Oncology, 2018, 45(3): 176-179.
[5]	Teng Fei, Cui Guimin, Shi Hongyun, Liu Miaoling, Li Yanhong. Clinical observation of radiotherapy combined with temozolomide in non-small cell lung cancer patients with brain metastases [J]. Journal of International Oncology, 2017, 44(4): 271-273.
[6]	刘梦实，杨海燕，李红梅. Bevacizumab in the treatment of non-small-cell lung cancer with brain metastases [J]. Journal of International Oncology, 2017, 44(11): 864-865.
[7]	HOU Su-Juan, LIU Yuan-Shui, ZHAO Wen-Hua. Efficacy of cryoablation combined with zoledronic acid sequential therapy for bone metastases pain [J]. Journal of International Oncology, 2015, 42(4): 264-268.
[8]	Chen-Ya-Ping, JIANG Xiao-Xiao, JIANG Guan, FENG Shou-Xin. A Metaanalysis of transcatheter arterial chemoembolization comparing stereotactic body radiation therapy in patients for primary hepatic carcinoma [J]. Journal of International Oncology, 2015, 42(3): 182-187.
[9]	Lin Li, Zhou Fuxiang. Stereotactic body radiotherapy for early stage nonsmall cell lung cancer [J]. Journal of International Oncology, 2015, 42(10): 773-775.
[10]	SUN Shan-Shan, ZHANG Yue-Meng, GAO Ying-Jie, GAO Wen-Cang. Research progress of bonemodifying agents in the treatment of bone metastases [J]. Journal of International Oncology, 2014, 41(3): 226-228.
[11]	SUN Shan-Shan, GAO Wen-Cang-. Research progress of bone metabolic markers [J]. Journal of International Oncology, 2013, 40(7): 546-548.

Application of stereotactic body radiotherapy in extracranial metastases

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 11

Recommended Articles

Metrics

Comments